Are there lung cancer (diagnosis) clinical trials in New York?

Yes. We're currently tracking 124 recruiting lung cancer (diagnosis) studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a lung cancer (diagnosis) study in New York?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New York to take part?

Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a lung cancer (diagnosis) trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New York

Lung Cancer (Diagnosis) clinical trials in New York

We’re tracking 124 recruiting lung cancer (diagnosis) studies with a site in New York — including Phase 1, Phase 2 and Phase 2/Phase 3 studies, each written for real people, not researchers.

Recruiting studies in New York

NCT05245500RecruitingPhase 1
Study drug for solid tumors with MTAP gene deletion
This Phase 1 trial studies MRTX1719, a new medicine, in solid tumors that have a missing MTAP gene (MTAP deletion). It aims to find the safest dose and check how the drug affects the tumor.
Mineola, New YorkAges 18 years+
NCT04949464Recruiting
Smoking quit coaching plus lung scans for people with HIV
This study tests a behavior-change program to help people with HIV quit smoking, along with routine low-dose lung CT scans to find warning signs early. It’s a feasibility study, meaning the main goal is to see if the approach is practical and acceptable, and if people can follow through.
New York, New YorkAges 45–80
NCT05354570RecruitingPhase 2
Radiation for thymic cancer that has spread to lung lining
This Phase 2 study tests a precise type of chest radiation that targets cancer in the lung lining (pleura) while trying to protect healthy lungs and organs. It may help people with thymic cancer that has spread to the pleura, including cases that return after prior treatment.
Commack, New YorkAges 18–79
NCT05058651RecruitingPhase 2/Phase 3
Atezolizumab plus chemo for advanced neuroendocrine cancer outside the lung
This trial tests whether adding an immunotherapy drug called atezolizumab to standard chemotherapy helps people with advanced neuroendocrine carcinoma (a rare and aggressive cancer) that started outside the lung. The goal is to see if the combination works better than chemo alone.
Buffalo, New YorkAges 18 years+

Where these studies are running in New York

Institutions with a site for the recruiting lung cancer (diagnosis) studies listed above.

Icahn School of Medicine at Mount Sinai / Mount Sinai Hospital · 2 studies
David H Koch, Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack
Memorial Sloan Kettering Nassau
Memorial Sloan Kettering Westchester
Montefiore Medical Center
New york cancer and blood specialists - Oncology

What taking part in a lung cancer (diagnosis) study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Lung Cancer (Diagnosis) trials in other states

Common questions

Are there lung cancer (diagnosis) clinical trials in New York?: Yes. We're currently tracking 124 recruiting lung cancer (diagnosis) studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a lung cancer (diagnosis) study in New York?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New York to take part?: Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a lung cancer (diagnosis) trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New lung cancer (diagnosis) studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.